Hosted on MSN2mon
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease“There’s very clearly some neurotropic aspect to GLP-1, in the sense the drugs actually reduce risk of quite a number of neurologic conditions,” the researcher says. In the category of ...
This goal is the focus of one of three recent major drug delivery deals ... licensing agreement allowing Astellas to use Sangamo’s neurotropic AAV capsid, known as STAC-BBB, to deliver genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results